The Pennant Group, Inc. logo

The Pennant Group, Inc.

PNTG

NASDAQHealthcareMedical - Care Facilities

Previous close

$38.88

−$0.12 · -0.31%

Aug 21, 4:00 PM ET

PNTG company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

77

Undervalued

Momentum

69

Gaining

Sentiment

60

Mixed

Risk resilience

66

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

The Pennant Group, Inc. is a U.S.-based healthcare provider, delivering a diverse range of services through two core divisions: Home Health and Hospice Services, and Senior Living Services. The company's Home Health segment offers in-home clinical support, encompassing nursing, speech, occupational, and physical therapy, as well as medical social work and home health aide assistance. Its Hospice services focus on providing comprehensive clinical care, education, and counseling to meet the physical, spiritual, and psychosocial needs of terminally ill patients and their families. In its Senior Living division, Pennant provides residential accommodations, organized activities, meals, housekeeping, and aid with daily living tasks for seniors who are either independent or require some support. As of December 31, 2021, the company's extensive operational footprint included 88 home health and hospice agencies and 54 senior living communities, collectively featuring 4,127 senior living units. These facilities are located across Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was established in 2019 and maintains its corporate headquarters in Eagle, Idaho.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
Brent J. Guerisoli
Listed since
Oct 1, 2019
Employees
9,700

Market position

Day range

Current $38.88

52-week range

Current $38.88

Open
$39.23
Previous close
$39.00
Volume
341.28K
1.22× average
Average volume
278.9K
Average daily volume
Market cap
1.35B USD
Beta
1.29
Market reference 1
50-day average
$38.448
+1.12% above average
200-day average
$32.466
+19.76% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1.41B USD
P/E (TTM)
41.36×
P/B (TTM)
3.77×
P/S (TTM)
1.23×
EV / EBITDA
23.16×
Earnings yield
3.04%
Free cash flow yield
2.70%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
14.79%
Operating margin
5.77%
Net margin
2.93%
Return on equity
8.89%
Return on assets
3.06%
Return on invested capital
4.47%

Financial health

Debt / equity
1.38×
Current ratio
1.14×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends15%10%4%-1%Gross margin, FY2021: 11.05%Gross margin, FY2022: 12.38%Gross margin, FY2023: 12.30%Gross margin, FY2024: 13.49%Gross margin, FY2025: 12.92%Operating margin, FY2021: 1.07%Operating margin, FY2022: 2.69%Operating margin, FY2023: 4.62%Operating margin, FY2024: 5.48%Operating margin, FY2025: 5.42%Net margin, FY2021: 0.61%Net margin, FY2022: 1.40%Net margin, FY2023: 2.46%Net margin, FY2024: 3.24%Net margin, FY2025: 3.12%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 11.05%. Gross margin FY2022 12.38%. Gross margin FY2023 12.30%. Gross margin FY2024 13.49%. Gross margin FY2025 12.92%. Operating margin FY2021 1.07%. Operating margin FY2022 2.69%. Operating margin FY2023 4.62%. Operating margin FY2024 5.48%. Operating margin FY2025 5.42%. Net margin FY2021 0.61%. Net margin FY2022 1.40%. Net margin FY2023 2.46%. Net margin FY2024 3.24%. Net margin FY2025 3.12%.

Income trends

Revenue

947.71M USD+36.31%

Operating income

51.39M USD+34.83%

Net income

29.58M USD+31.11%
Income trends across reported periods1.04B USD664.2M USD286.2M USD−91.8M USDRevenue, FY2021: 439.69M USDRevenue, FY2022: 473.24M USDRevenue, FY2023: 544.89M USDRevenue, FY2024: 695.24M USDRevenue, FY2025: 947.71M USDOperating income, FY2021: 4.7M USDOperating income, FY2022: 12.74M USDOperating income, FY2023: 25.17M USDOperating income, FY2024: 38.12M USDOperating income, FY2025: 51.39M USDNet income, FY2021: 2.7M USDNet income, FY2022: 6.64M USDNet income, FY2023: 13.38M USDNet income, FY2024: 22.56M USDNet income, FY2025: 29.58M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 439.69M USD. Revenue FY2022 473.24M USD. Revenue FY2023 544.89M USD. Revenue FY2024 695.24M USD. Revenue FY2025 947.71M USD. Operating income FY2021 4.7M USD. Operating income FY2022 12.74M USD. Operating income FY2023 25.17M USD. Operating income FY2024 38.12M USD. Operating income FY2025 51.39M USD. Net income FY2021 2.7M USD. Net income FY2022 6.64M USD. Net income FY2023 13.38M USD. Net income FY2024 22.56M USD. Net income FY2025 29.58M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue947.71M USD695.24M USD544.89M USD473.24M USD439.69M USD
Cost of goods sold825.24M USD601.48M USD477.86M USD414.66M USD391.1M USD
Gross profit122.47M USD93.76M USD67.04M USD58.59M USD48.6M USD
Selling, general, and administrative71.08M USD50.21M USD36.67M USD33.98M USD36.26M USD
Operating expenses71.08M USD55.65M USD41.87M USD45.85M USD43.9M USD
Interest expense6.68M USD6.96M USD5.92M USD3.82M USD1.94M USD
Depreciation and amortization8.54M USD6.12M USD5.13M USD4.9M USD4.78M USD
Operating income51.39M USD38.12M USD25.17M USD12.74M USD4.7M USD
Net income29.58M USD22.56M USD13.38M USD6.64M USD2.7M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
82%
9 beats, 0 misses, 2 met estimates
Average EPS surprise
+8.30%
11 comparable reports
Latest EPS result
0.36
Estimate 0.33 · Beat by 8.56%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.40.330.260.19Q1 '25MetQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 0.24, estimate 0.24, surprise 0.00%, Met estimate. Q2 2025, reported May 6, 2025: actual 0.27, estimate 0.22, surprise +22.73%, Beat. Q3 2025, reported Aug 6, 2025: actual 0.27, estimate 0.26, surprise +3.85%, Beat. Q4 2025, reported Nov 5, 2025: actual 0.3, estimate 0.29, surprise +3.45%, Beat. Q1 2026, reported Feb 25, 2026: actual 0.34, estimate 0.31, surprise +9.68%, Beat. Q2 2026, reported May 6, 2026: actual 0.32, estimate 0.31, surprise +3.23%, Beat. Q3 2026, reported Aug 5, 2026: actual 0.36, estimate 0.332, surprise +8.56%, Beat. Q4 2026, reported Nov 4, 2026: actual —, estimate 0.33, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates311.31M265.49M219.67M173.86MQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 188.89M USD, estimate 185.83M USD, surprise +1.65%, Beat. Q2 2025, reported May 6, 2025: actual 209.84M USD, estimate 201.46M USD, surprise +4.16%, Beat. Q3 2025, reported Aug 6, 2025: actual 219.5M USD, estimate 214.61M USD, surprise +2.28%, Beat. Q4 2025, reported Nov 5, 2025: actual 229.04M USD, estimate 275.2M USD, surprise -16.77%, Miss. Q1 2026, reported Feb 25, 2026: actual 289.32M USD, estimate 275.19M USD, surprise +5.14%, Beat. Q2 2026, reported May 6, 2026: actual 285.36M USD, estimate 280.75M USD, surprise +1.64%, Beat. Q3 2026, reported Aug 5, 2026: actual 297.98M USD, estimate 288.71M USD, surprise +3.21%, Beat. Q4 2026, reported Nov 4, 2026: actual —, estimate 299.34M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

7 ratings
Strong buy00%
Buy686%
Hold114%
Sell00%
Strong sell00%

PNTG news

PNTG peers

ETFs holding PNTG

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research PNTG

research.disclaimer